Background: Pathogenic variants in GCH1 have been associated with Parkinson’s disease (PD), but the clinical phenotype and longitudinal disease course of GCH1-associated PD remain incompletely characterized. Objectives: To characterize the genetic spectrum, clinical phenotype, and longitudinal progression of GCH1-associated PD across multiple populations. Methods: Whole-genome sequencing (WGS) and clinical exome sequencing (CES) data from the Global Parkinson Genetics Program (GP2) were analyzed together with unpublished and published GCH1-associated PD patients.
GCH1 genetic variation as a prognostic factor in Parkinson disease across populations
calendar_today
August 14, 2026
person
Shin, J. H., Perinan, M. T., Jang, J. W., Screven, L., Lange, L. M., Klein, C., Shulman, J. M., Gan-Or, Z., Shahkhali, M. G., Senkevich, K., Dusek, P., Miliukhina, I., Alcalay, R. N., Lin, C.-H., Wu, R.-M., Morris, H. R., Tan, E.-K., Zhang, B.-R., Cogan, G., Brice, A., Mencacci, N. E., Sarmiento, I. J. K., Simuni, T., Sassi, S. B., Marti, M. J., Pastor, P., Tay, Y. W., Tan, A. H., Lim, S.-Y., Stamelou, M., Chafota, F., Renteria, M. E., Mohamed, W., Mata, I. F., Cornejo Olivas, M., Cesarini, M., Rivera, A., Avenali, M., Valente, E. M., Foroud, T. M., Nudelman, K. N. H., Brumm, M. C., Gasser, T.
domain
medrxiv